Hyperuricemic nephropathies.

[1]  F. Coe.  Nephrolithiasis: Pathogenesis and Treatment , 1988 .

[2]  D. L. Scott,et al.  Clinics in Rheumatic Diseases , 1984 .

[3]  N. Edwards,et al.  Enhanced purine salvage during allopurinol therapy: an important pharmacologic property in humans. , 1981, The Journal of laboratory and clinical medicine.

[4]  F. Davis,et al.  Reduction of plasma urate levels in the cockerel with polyethylene glycol-uricase. , 1981, The Journal of pharmacology and experimental therapeutics.

[5]  F. Davis,et al.  HYPOURICAEMIC EFFECT OF POLYETHYLENEGLYCOL MODIFIED URATE OXIDASE , 1981, The Lancet.

[6]  I. Magrath,et al.  Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. , 1981, Medicine.

[7]  Fitzgerald Rh,et al.  Acute obstructive uric acid nephropathy after treatment of neoplastic adenopathy. , 1981 .

[8]  J. Conger.  Acute uric acid nephropathy. , 1981, The Medical clinics of North America.

[9]  V. Cirillo,et al.  Enhancement of uricosuric properties of indacrinone by manipulation of the enantiomer ratio , 1981, Clinical pharmacology and therapeutics.

[10]  R. Wortmann,et al.  Limited value of uric acid to creatinine ratios in estimating uric acid excretion. , 1980, Annals of internal medicine.

[11]  Steimer Jl,et al.  [Bioequivalence of dosage forms. The confidence interval approach. Westlake's method (author's transl)]. , 1980 .

[12]  H. Simmonds,et al.  Familial gout and renal failure in young women. , 1980, Clinical nephrology.

[13]  B. Emmerson,et al.  Indacrinone: Modification of diuretic, uricosuric, and kaliuretic actions by amiloride , 1980, Clinical pharmacology and therapeutics.

[14]  I. Magrath,et al.  Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphoma , 1980 .

[15]  W. Fessel.  High uric acid as an indicator of cardiovascular disease. Independence from obesity. , 1980, The American journal of medicine.

[16]  D. Mclain,et al.  Adverse reactions associated with ticrynafen use. , 1980, JAMA.

[17]  M. Fernandes,et al.  Acute renal failure during treatment with ticrynafen. , 1980, JAMA.

[18]  R. Wahl,et al.  Acute renal failure associated with ticrynafen. , 1980, JAMA.

[19]  W. Bennett,et al.  Acute renal failure from ticrynafen. , 1979, The New England journal of medicine.

[20]  R. Elin,et al.  Hyperxanthinemia interferes with serum uric acid determinations by the uricase method. , 1979, Clinical chemistry.

[21]  D. Alling,et al.  A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. , 1979, The New England journal of medicine.

[22]  W. Fessel.  Renal outcomes of gout and hyperuricemia. , 1979, The American journal of medicine.

[23]  P. Hoover,et al.  Uric acid excretion: quantitative assessment from spot, midmorning serum and urine samples. , 1979, Annals of internal medicine.

[24]  G. Richet,et al.  Extreme hyperphosphataemia causing acute anuric nephrocalcinosis in lymphosarcoma. , 1979, British medical journal.

[25]  Schrier Rw.  Nephrology forum: acute renal failure. , 1979, Kidney international.

[26]  T. Yü.  Cystic diseases of the kidney and gout. , 1978 .

[27]  G. Thompson,et al.  Familial occurrence of hyperuricemia, gout, and medullary cystic disease. , 1978, Archives of internal medicine.

[28]  I. Sharlip,et al.  Dissolution of bilateral uric acid calculi causing anuria. , 1978, JAMA.

[29]  M. Liang,et al.  Asymptomatic hyperuricemia: the case for conservative management. , 1978, Annals of internal medicine.

[30]  E. Holmes,et al.  A rapid method for the diagnosis of acute uric acid nephropathy. , 1978, Archives of internal medicine.

[31]  Lynch Ec,et al.  Acute renal failure in patients with acute leukemia. , 1978 .

[32]  T. Higenbottam,et al.  Acute renal failure from the use of acetazolamide (Diamox). , 1978, Postgraduate medical journal.

[33]  P. Lewy,et al.  Possible urate nephropathy of the newborn infant as a cause of transient renal insufficiency. , 1977, The Journal of pediatrics.

[34]  S. Falk,et al.  Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. , 1977, The Journal of clinical investigation.

[35]  G. Fanelli,et al.  Saluretic and uricosuric effects of (6, 7-dichloro-2-methyl=1-oxo-2-phenyl-5-indanyloxy) acetic acid (MK-196) in the chimpanzee. , 1977, The Journal of pharmacology and experimental therapeutics.

[36]  R. Yolken,et al.  Hyperuricemia and renal failure-presenting manifestations of occult hematologic malignancies. , 1976, The Journal of pediatrics.

[37]  G. Eknoyan,et al.  Dissociation of urate from sodium transport in the rat proximal tubule.=. , 1976, Kidney international.

[38]  S. Falk,et al.  A micropuncture study of the early phase of acute urate nephropathy. , 1976, The Journal of clinical investigation.

[39]  R. Zittoun,et al.  [Treatment of hyperuricemias in hematology using urate oxidase and allopurinol]. , 1976, Annales de medecine interne.

[40]  T. H. Steele,et al.  Renal transport of urate during diuretic-induced hypouricemia. , 1976, The American journal of medicine.

[41]  T. Yü,et al.  Renal function in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies. , 1975, The American journal of medicine.

[42]  Y. Kanwar,et al.  Leukemic urate nephropathy. , 1975, Archives of pathology.

[43]  D. Warren,et al.  HYPERURICÆMIC ACUTE RENAL FAILURE AFTER EPILEPTIC SEIZURES , 1975, The Lancet.

[44]  B. Emmerson,et al.  An evaluation of the pathogenesis of the gouty kidney , 1975 .

[45]  S. Steinberg,et al.  Hemodialysis for acute anuric uric acid nephropathy. , 1975, American journal of diseases of children.

[46]  T. Yü,et al.  Renal disease in primary gout: a study of 253 gout patients with proteinuria. , 1975, Seminars in arthritis and rheumatism.

[47]  T. Murray,et al.  Chronic interstitial nephritis: etiologic factors. , 1975, Annals of internal medicine.

[48]  M. A. Manuel,et al.  Changes in renal urate handling after prolonged thiazide treatment. , 1974, The American journal of medicine.

[49]  C. Kjellstrand,et al.  Hyperuricemic acute renal failure. , 1974, Archives of internal medicine.

[50]  A. Siegelaub,et al.  Correlates and consequences of asymptomatic hyperuricemia. , 1973, Archives of internal medicine.

[51]  G. Boner,et al.  Origins of the uricosuric response. , 1973, The Journal of clinical investigation.

[52]  B. Emmerson,et al.  The spectrum of hypoxanthine-guanine phosphoribosyltransferase deficiency. , 1973, The Quarterly journal of medicine.

[53]  B. G. Stephens,et al.  Nephropathy, xanthinuria, and orotic aciduria complicating Burkitt's lymphoma treated with chemotherapy and allopurinol. , 1972, Metabolism: clinical and experimental.

[54]  J. Loeb.  The influence of temperature on the solubility of monosodium urate. , 1972, Arthritis and rheumatism.

[55]  Wagoner Rd,et al.  Peritoneal dialysis in acute uric acid nephropathy. , 1972 .

[56]  L. Reese,et al.  Management of acute renal failure due to marked hyperuricemia. , 1972, Canadian Medical Association journal.

[57]  Handa Sp.  Acute renal railure in association with hyperuricemia: its recovery with ethacrynic acid. , 1971 .

[58]  R. Rieselbach,et al.  Diminished renal urate secretion per nephron as a basis for primary gout. , 1970, Annals of internal medicine.

[59]  P. Band,et al.  Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. , 1970, The New England journal of medicine.

[60]  B. Cohen,et al.  Hyperuricemic nephropathy. Report of a case of lymphoblastic lymphosarcoma. , 1970, American journal of diseases of children.

[61]  T. H. Steele,et al.  Factors affecting urate excretion following diuretic administration in man. , 1969, The American journal of medicine.

[62]  W. T. Caraway.  Non-urate chromogens in body fluids. , 1969, Clinical chemistry.

[63]  E. Prien,et al.  Composition and structure of urinary stone. , 1968, The American journal of medicine.

[64]  P. Cannon,et al.  The Distribution of Urate in Human and Primate Kidney∗ , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[65]  G. Hitchings,et al.  Renal clearance of oxipurinol, the chief metabolite of allopurinol. , 1968, The American journal of medicine.

[66]  Kann He,et al.  The development and use of an intravenous preparation of allopurinol. , 1968 .

[67]  J. Zilva,et al.  Determination of uric acid levels in uraemia by enzymatic and colorimetric techniques , 1968, Journal of clinical pathology.

[68]  N. Holland,et al.  Prevention and management of acute hyperuricemia in childhood leukemia. , 1968, The Journal of pediatrics.

[69]  A. Gutman,et al.  Uric acid nephrolithiasis in gout. Predisposing factors. , 1967, Annals of internal medicine.

[70]  J. Knochel,et al.  Nonoliguric acute renal failure. , 1967, JAMA.

[71]  R. Deconti,et al.  Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease. , 1966, The New England journal of medicine.

[72]  P. Watkins,et al.  Allopurinal and acute uric acid nephropathy. , 1966, British medical journal.

[73]  R. Rieselbach,et al.  URIC ACID EXCRETION AND RENAL FUNCTION IN THE ACUTE HYPERURICEMIA OF LEUKEMIA. PATHOGENESIS AND THERAPY OF URIC ACID NEPHROPATHY. , 1964, The American journal of medicine.

[74]  W. Crosby,et al.  Acute uric acid nephropathy. Treatment with mannitol diuresis and peritoneal dialysis. , 1963, Archives of internal medicine.

[75]  K. Terplán,et al.  The Kidney in Gout , 1960, Medicine.

[76]  R. Kritzler.  Anuria complicating the treatment of leukemia. , 1958, The American journal of medicine.

[77]  L. Craver,et al.  Uremia complicating leukemia chemotherapy; report of a case treated with triethylene melamine. , 1951, Journal of the American Medical Association.

[78]  G. Oppenheimer,et al.  Anuria following radiation therapy in leukemia. , 1950, Journal of the American Medical Association.

[79]  H. Jackson,et al.  The Renal Complications of Leukemia , 1943 .

[80]  T. H. Steele.  Mechanism of the uricosuric activity of ticrynafen. , 1979, Nephron.

[81]  Steele Th.  Renal handling of urate: application to the action of tienilic acid. , 1979 .

[82]  J. Brogard,et al.  Enzymatic Uricolysis and Its Use in Therapy , 1978 .

[83]  T. H. Steele.  Urate Excretion in Man, Normal and Gouty , 1978 .

[84]  G. Elion.  Allopurinol and Other Inhibitors of Urate Synthesis , 1978 .

[85]  N. Ertel,et al.  Pharmacology of Drugs Used in Treatment of Acute Gout , 1978 .

[86]  I. Weiner,et al.  Diuretic-induced uricosuria: interaction with pyrazinoate transport in man. , 1977, The Journal of pharmacology and experimental therapeutics.

[87]  M. Kauker.  Clearance and micropuncture studies of the effects of a new indanyloxyacetic acid diuretic on segmental nephron function in rats. , 1977, The Journal of pharmacology and experimental therapeutics.

[88]  G. L. Ackerman,et al.  Hyperuricemic acute renal failure in disseminated carcinoma. , 1977, Archives of internal medicine.

[89]  Jacques Genest,et al.  Hypertension: Physiopathology and treatment , 1977 .

[90]  D. Mitchison,et al.  Letter: False-positive acid-fast smears. , 1975, Lancet.

[91]  W. Kelley.  Pharmacologic approach to the maintenance of urate homeostasis. , 1975, Nephron.

[92]  B. Finlayson,et al.  Stability of first dissociable proton of uric acid , 1974 .

[93]  J. Maher,et al.  Hyperuricemia complicating leukemia: treatment with allopurinol and dialysis. , 1969, Archives of internal medicine.

[94]  P. Ganter,et al.  Les tophus goutteux de la médullaire rénale des urémiques chroniques , 1967 .

[95]  T. Dawber,et al.  Epidemiology of gout and hyperuricemia. A long-term population study. , 1967, The American journal of medicine.

[96]  A. Gutman,et al.  Uricosuric drugs, with special reference to probenecid and sulfinpyrazone. , 1966, Advances in pharmacology.

[97]  J. Ultmann.  Hyperuricemia in disseminated neoplastic disease other than lymphomas and leukemias , 1962, Cancer.